Where B. burgdorferi EIA (screening) is reported
Also listed as: Enzyme immunoassay — tier 1
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Lyme Disease | ↑ elevated | Uninfected | Active or past Lyme infection | CDC 2024 |
Frequently asked questions
In which conditions is B. burgdorferi EIA (screening) altered?
In the OSMF atlas B. burgdorferi EIA (screening) is reported in Lyme Disease. It is elevated in 1 across 1 entries.
Is there a standard clinical test for B. burgdorferi EIA (screening)?
The atlas entries for B. burgdorferi EIA (screening) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal B. burgdorferi EIA (screening) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.